Skip to search.
 TSX Down 2.15% TSX Ventures Down 1.81%

Abbott Laboratories (ABT)

-NYSE
49.01 Down 0.96(1.92%) Jun 29, 4:00PM EDT
Add to Portfolio
Prev Close:49.97
Open:49.54
Bid:46.00 x 300
Ask:49.82 x 200
1y Target Est:51.41
Beta:1.3
Earnings Date:Jul 14 - Jul 20 (Est.)
Day's Range:48.96 - 49.85
52wk Range:39.28 - 50.47
Volume:5,364,310
Avg Vol (3m):4,680,410
Market Cap:72.96B
P/E (ttm):17.73
EPS (ttm):2.76
Div & Yield:0.96 (1.90%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTDown 1.92%72.96B
NSRGYDown 0.98%N/A
RHHBYDown 2.31%N/A
TEVAUp 0.78%50.35B

Key Statistics

Forward P/E (1 yr):20.34
P/S (ttm):3.65
Ex-Dividend Date:13-Jul-15

Analysts

Annual EPS Est (Dec-15) :2.16
Quarterly EPS Est (Jun-15) :0.50
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.36

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; int... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback